General Information of the Compound
| Compound ID |
CP0848531
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-(2,6-difluorophenyl)-3-[3-(2-{[4-[1'-(2-fluoroethyl)-4,4'-bipiperidin-1-yl]-2-(methyloxy)phenyl]amino}-4-pyrimidinyl)imidazo[1,2-a]pyridin-2-yl]benzamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C43H43F3N8O2
|
||||||||||||||||||
| Molecular Weight |
760.865
|
||||||||||||||||||
| Canonical SMILES |
COc1cc(N2CCC(C3CCN(CCF)CC3)CC2)ccc1Nc1nccc(-c2c(-c3cccc(C(=O)Nc4c(F)cccc4F)c3)nc3ccccn23)n1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C43H43F3N8O2/c1-56-37-27-32(53-23-16-29(17-24-53)28-14-21-52(22-15-28)25-18-44)11-12-35(37)48-43-47-19-13-36(49-43)41-39(50-38-10-2-3-20-54(38)41)30-6-4-7-31(26-30)42(55)51-40-33(45)8-5-9-34(40)46/h2-13,19-20,26-29H,14-18,21-25H2,1H3,(H,51,55)(H,47,48,49)
Show/Hide
|
||||||||||||||||||
| InChIKey |
RDGFRNBJLDAZEJ-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01101, Insulin receptor
Protein ID: PT01104, Insulin-like growth factor 1 receptor